Alan M. Pearce
Plus aucun poste en cours
Profil
Alan M.
Pearce served as a Director at BioDelivery Sciences International, Inc. from 2002 to 2005, and at Accentia Biopharmaceuticals, Inc. from 2004 to 2010.
He was also a Senior Vice President-Financial Services at McKesson Corp.
from 1999 to 2004, and the Chief Financial Officer at BioVest International, Inc. from 2007 to 2010.
Pearce received his undergraduate degree from Georgia Institute of Technology and his MBA from The University of Texas at Austin.
Anciens postes connus de Alan M. Pearce
| Sociétés | Poste | Fin |
|---|---|---|
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Directeur Financier/CFO | 31/12/2010 |
| ACCENTIA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 31/12/2010 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur/Membre du Conseil | 01/09/2005 |
| MCKESSON CORPORATION | Corporate Officer/Principal | 01/03/2004 |
XL Insurance (Bermuda) Ltd.
 XL Insurance (Bermuda) Ltd. Insurance Brokers/ServicesFinance XL Insurance (Bermuda) Ltd. provides liability insurance coverage services. The firm offers insurance and reinsurance coverages, and financial products & services to industrial, commercial, and professional service firms, insurance companies, and other enterprises worldwide. The company has operating divisions in Australia, the Czech Republic, France, Hungary, and Ireland. The company was established in 1986 and is headquartered in Hamilton, Bermuda. | Directeur/Membre du Conseil | - |
Formation de Alan M. Pearce
| The University of Texas at Austin | Masters Business Admin |
| Georgia Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MCKESSON CORPORATION | Distribution Services |
| Entreprise privées | 4 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
XL Insurance (Bermuda) Ltd.
XL Insurance (Bermuda) Ltd. Insurance Brokers/ServicesFinance XL Insurance (Bermuda) Ltd. provides liability insurance coverage services. The firm offers insurance and reinsurance coverages, and financial products & services to industrial, commercial, and professional service firms, insurance companies, and other enterprises worldwide. The company has operating divisions in Australia, the Czech Republic, France, Hungary, and Ireland. The company was established in 1986 and is headquartered in Hamilton, Bermuda. | Finance |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
